PlainRecalls
FDA Drug Moderate Class II Terminated

Phenylephrine HCI Injection, USP, 10mg/mL, packaged in a) 5 mL Vial, 50 mg/5 mL (NDC 66758-016-03), 25 x 5 mL Vials per carton (NDC 66758-016-04) and b) 10 mL Vials, 100 mg/10 mL (NDC 66758-017-01), Rx only, Manufactured for: Sandoz Inc., Princeton, NJ 08540.

Reported: September 28, 2016 Initiated: August 24, 2016 #D-1514-2016

Product Description

Phenylephrine HCI Injection, USP, 10mg/mL, packaged in a) 5 mL Vial, 50 mg/5 mL (NDC 66758-016-03), 25 x 5 mL Vials per carton (NDC 66758-016-04) and b) 10 mL Vials, 100 mg/10 mL (NDC 66758-017-01), Rx only, Manufactured for: Sandoz Inc., Princeton, NJ 08540.

Reason for Recall

Lack of Assurance of Sterility: a recent FDA inspection at the manufacturing firm raised concerns that product sterility may be compromised.

Details

Recalling Firm
Sandoz Inc
Units Affected
a) 1,584 cartons; b) 62,170 vials
Distribution
Nationwide and Puerto Rico
Location
Princeton, NJ

Frequently Asked Questions

What product was recalled?
Phenylephrine HCI Injection, USP, 10mg/mL, packaged in a) 5 mL Vial, 50 mg/5 mL (NDC 66758-016-03), 25 x 5 mL Vials per carton (NDC 66758-016-04) and b) 10 mL Vials, 100 mg/10 mL (NDC 66758-017-01), Rx only, Manufactured for: Sandoz Inc., Princeton, NJ 08540.. Recalled by Sandoz Inc. Units affected: a) 1,584 cartons; b) 62,170 vials.
Why was this product recalled?
Lack of Assurance of Sterility: a recent FDA inspection at the manufacturing firm raised concerns that product sterility may be compromised.
Which agency issued this recall?
This recall was issued by the FDA Drug on September 28, 2016. Severity: Moderate. Recall number: D-1514-2016.